为了血液和金钱：亿万富翁、生物技术和对重磅药物的探索 For Blood and Money: Billionaires, Biotech, and the Quest for a Blockbuster medicine 英文原版 Nathan Vardi 

基本信息

ISBN:9781324074755

Weight:236g

Dimensions:210 x 139 x 20 (mm)

Language:English

Country of Origin:GB

Tariff Codes:49019900

书籍信息仅供参考，具体以实物为准

书籍简介

《为了血液和金钱》讲述了一个鲜为人知的故事：一家新成立的生物技术公司如何创造出百万分之一的癌症药物，以及核心团队如何在被剥夺利润份额的情况下，再次创造出这种药物。在这个关于金钱和科学的史诗般的传奇故事中，金融记者内森-瓦尔迪解释了历史上两种较大的癌症药物的发明如何成为（对其支持者而言）有史以来华尔街伟大的赌注。

在价值数十亿美元的生物技术行业中，制药公司、政府、对冲基金和风险资本家在资金、实验和治疗方面花费了数十亿美元，一个分子就可以阻止癌症的发生，并使发现这种罕见分子的人获得惊人的财富。《为了血液和金钱》讲述了加州一家生物技术初创公司的一个小团队，他们找到了这种罕见的分子之一。他们的化合物被称为BTK抑制剂，似乎对一种恶性的白血病有效。当病人开始从他们的临终关怀病床上站起来时，该团队知道他们遇到了大问题。

接下来是一个充满天才、悲怆和戏剧性的故事，其中生动的人物在一个充满企业阴谋和模糊道德的世界中穿梭。瓦尔迪的叙述让读者沉浸在近期生物技术创业的爆炸性增长中。他描述了那些冒着一切风险开发新的、拯救生命的治疗方法的科学家、医生和投资者，并介绍了那些生死攸关的痛苦病人。作为一本扣人心弦的非虚构读物，《为了血液和金钱》说明了将新药推向市场为何如此困难，解释了它们为何如此昂贵，并研究了利润驱动的风险资本家如何塑造医学的未来。

For Blood and Money tells the little-known story of how an upstart biotechnology company created a one-in-a-million cancer drug, and how the core team—denied their share of the profits—went and did it again. In this epic saga of money and science, veteran financial journalist Nathan Vardi explains how the invention of two of the biggest cancer drugs in history became (for their backers) two of the greatest Wall Street bets of all time.

In the multibillion-dollar business of biotech, where pharmaceutical companies, the government, hedge funds, and venture capitalists have spent billions on funding, experimentation, and treatments, a single molecule can stop cancer in its tracks—and make the people who find that rare molecule astonishingly rich. For Blood and Money follows a small team at a biotech start-up in California, who have found one of these rare molecules. Their compound, known as a BTK inhibitor, seems to work on a vicious type of leukemia. When patients start rising from their hospice beds, the team knows they’re onto something big.

What follows is a story of genius, pathos, and drama, in which vivid characters navigate a world of corporate intrigue and ambiguous morality. Vardi’s narrative immerses readers in the recent explosion of biotech start-ups. He describes the scientists, doctors, and investors who are risking everything to develop new, life-saving treatments, and introduces suffering patients for whom the stakes are life-or-death. A gripping nonfiction read, For Blood and Money illustrates why it’s so hard to bring new drugs to market, explains why they are so expensive, and examines how profit-driven venture capitalists are shaping the future of medicine.

作者简介

内森-瓦尔迪是MarketWatch的执行编辑，曾任福布斯的高级编辑。他撰写关于大资金投资者、对冲基金、私募股权公司以及华尔街和生物制药的交集的文章。他住在纽约的Edgemont。

Nathan Vardi is a managing editor at MarketWatch and former senior editor at Forbes. He writes about big money investors, hedge funds, private equity firms, and the intersection of Wall Street and biopharma. He lives in Edgemont, New York.